iohexol has been researched along with Minimal Disease, Residual in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The accuracy for detection of residual tumor by the different imaging modalities following RFA was assessed." | 2.72 | Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. ( Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vandenbroucke, F | 1 |
| Vandemeulebroucke, J | 1 |
| Ilsen, B | 1 |
| Verdries, D | 1 |
| Belsack, D | 1 |
| Everaert, H | 1 |
| Buls, N | 1 |
| Ros, PR | 1 |
| de Mey, J | 1 |
| Spira, D | 1 |
| Vogel, W | 1 |
| Sökler, M | 1 |
| Löffler, S | 1 |
| Sauter, A | 1 |
| Schulze, M | 1 |
| Horger, M | 1 |
| Lakhman, Y | 1 |
| Akin, O | 1 |
| Sohn, MJ | 1 |
| Zheng, J | 1 |
| Moskowitz, CS | 1 |
| Iyer, RB | 1 |
| Barakat, RR | 1 |
| Sabbatini, PJ | 1 |
| Chi, DS | 1 |
| Hricak, H | 1 |
| Veit, P | 1 |
| Antoch, G | 1 |
| Stergar, H | 1 |
| Bockisch, A | 1 |
| Forsting, M | 1 |
| Kuehl, H | 1 |
| Nicoletti, GF | 1 |
| Barone, F | 1 |
| Passanisi, M | 1 |
| Mancuso, P | 1 |
| Albanese, V | 1 |
1 trial available for iohexol and Minimal Disease, Residual
| Article | Year |
|---|---|
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follo | 2006 |
4 other studies available for iohexol and Minimal Disease, Residual
| Article | Year |
|---|---|
Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Topics: Catheter Ablation; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Iohexol; Liv | 2014 |
Size and attenuation CT (SACT) of residual masses in patients with follicular non-Hodgkin lymphoma: more than a status quo?
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; M | 2012 |
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
Topics: Contrast Media; Diatrizoate; Disease Progression; Fallopian Tube Diseases; Female; Humans; Iohexol; | 2012 |
Linear contrast enhancement at the operative site on early post-operative CT after removal of brain tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Cerebellar Neoplasms; Combined Modalit | 1994 |